首页 > 最新文献

中华肝胆外科杂志最新文献

英文 中文
Retrograde approach to the retroperitoneal Castleman disease: a case report and literature review 逆行入路治疗腹膜后Castleman病1例报告及文献复习
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.016
Jian-Ji Ke, Feiqi Liu, Wei Han, L. Meng, Yahui Liu
Castleman病又称血管滤泡性淋巴结增生症。患者男性,23岁,因体检发现腹腔占位2 d入院。增强CT提示肝脏与下腔静脉之间团块状肿物,边界清。为腹膜后肿物,并与胰头部、十二指肠等关系密切,术前诊断不明。行腹腔镜手术治疗,手术采用"后入路",术中分离肿物与周围脏器,仅行肿物切除。术后病理诊断为Castleman病,术后患者恢复良好。
Castleman's disease, also known as vascular follicular lymph node hyperplasia. The patient, a 23-year-old male, was admitted to the hospital 2 days after a physical examination revealed a space occupying the abdominal cavity. Enhanced CT shows a lumpy mass between the liver and the inferior vena cava, with a clear boundary. It is a retroperitoneal mass closely related to the head of the pancreas and duodenum, and the preoperative diagnosis is unknown. Laparoscopic surgery is performed, using a "posterior approach" to separate the tumor from surrounding organs and only perform tumor resection. The postoperative pathological diagnosis was Castleman's disease, and the patient recovered well after the surgery.
{"title":"Retrograde approach to the retroperitoneal Castleman disease: a case report and literature review","authors":"Jian-Ji Ke, Feiqi Liu, Wei Han, L. Meng, Yahui Liu","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.016","url":null,"abstract":"Castleman病又称血管滤泡性淋巴结增生症。患者男性,23岁,因体检发现腹腔占位2 d入院。增强CT提示肝脏与下腔静脉之间团块状肿物,边界清。为腹膜后肿物,并与胰头部、十二指肠等关系密切,术前诊断不明。行腹腔镜手术治疗,手术采用\"后入路\",术中分离肿物与周围脏器,仅行肿物切除。术后病理诊断为Castleman病,术后患者恢复良好。","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"221-222"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42030339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors in patients with occult ruptured hepatocellular carcinoma after hepatectomy 肝切除术后隐匿性破裂肝癌患者的预后因素分析
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.003
J. Kong, Zhiyong Sun, W. Shi, Y. Ye, Hui Li, Haiwang Zhao, Quan Xu
Objective To study the prognostic factors in patients with occult ruptured hepatocellular carcinoma (HCC) after hepatectomy. Methods The clinical data of 31 patients with occult ruptured HCC who underwent hepatectomy at the Heze Multiple Hospital from January 2001 to December 2014 were retrospectively analyzed. There were 27 males and 4 females, with ages ranging from 29 to 73 years. Kaplan-Meier survival analysis was carried out for survival analysis, and compared by the log-rank test. Multivariate analysis was conducted using the Cox proportional hazards regression model. Results Of 31 patients in this study, 27(87.1%) had died, and 25(80.6%) had developed tumor recurrence and metastasis. The median overall survival was 8 months and the median tumor-free survival was 4 months. On Cox regression analysis, non-R0 resection was an independent risk factor of overall survival (RR=2.816, 95%CI: 1.006-7.887) and disease-free survival (RR=3.295, 95%CI: 1.215-8.940). Poor tumor differentiation was an independent risk factor of overall survival (RR=3.120, 95%CI: 1.193-8.160). Conclusions The prognosis of patients with occult rupture HCC who underwent no R0 resection was poor. However, the prognosis of patients who underwent non-R0 resection was even poorer. Key words: Carcinoma, hepatocellular; Hepatectomy; Rupture; Prognosis; Influencing factor
目的探讨肝切除术后隐匿性破裂肝细胞癌(HCC)患者的预后因素。方法回顾性分析2001年1月至2014年12月在菏泽市综合医院接受肝切除术的31例隐匿性破裂HCC患者的临床资料。男27例,女4例,年龄29~73岁。采用Kaplan-Meier生存分析进行生存分析,并通过对数秩检验进行比较。使用Cox比例风险回归模型进行多变量分析。结果31例患者中,27例(87.1%)死亡,25例(80.6%)发生肿瘤复发和转移。中位总生存期为8个月,中位无瘤生存期为4个月。Cox回归分析显示,非R0切除是影响总生存率(RR=2.816,95%CI:1.006-7.887)和无病生存率(RR=3.295,95%CI:1.125-8.940)的独立危险因素。肿瘤分化不良是影响总存活率(RR=3.120,95%CI:1.193-8.160)的独立危险因素。然而,接受非R0切除术的患者的预后更差。关键词:肝癌;肝切除术;破裂;预后;影响因素
{"title":"Prognostic factors in patients with occult ruptured hepatocellular carcinoma after hepatectomy","authors":"J. Kong, Zhiyong Sun, W. Shi, Y. Ye, Hui Li, Haiwang Zhao, Quan Xu","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.003","url":null,"abstract":"Objective \u0000To study the prognostic factors in patients with occult ruptured hepatocellular carcinoma (HCC) after hepatectomy. \u0000 \u0000 \u0000Methods \u0000The clinical data of 31 patients with occult ruptured HCC who underwent hepatectomy at the Heze Multiple Hospital from January 2001 to December 2014 were retrospectively analyzed. There were 27 males and 4 females, with ages ranging from 29 to 73 years. Kaplan-Meier survival analysis was carried out for survival analysis, and compared by the log-rank test. Multivariate analysis was conducted using the Cox proportional hazards regression model. \u0000 \u0000 \u0000Results \u0000Of 31 patients in this study, 27(87.1%) had died, and 25(80.6%) had developed tumor recurrence and metastasis. The median overall survival was 8 months and the median tumor-free survival was 4 months. On Cox regression analysis, non-R0 resection was an independent risk factor of overall survival (RR=2.816, 95%CI: 1.006-7.887) and disease-free survival (RR=3.295, 95%CI: 1.215-8.940). Poor tumor differentiation was an independent risk factor of overall survival (RR=3.120, 95%CI: 1.193-8.160). \u0000 \u0000 \u0000Conclusions \u0000The prognosis of patients with occult rupture HCC who underwent no R0 resection was poor. However, the prognosis of patients who underwent non-R0 resection was even poorer. \u0000 \u0000 \u0000Key words: \u0000Carcinoma, hepatocellular; Hepatectomy; Rupture; Prognosis; Influencing factor","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"170-172"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48438196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined laparoscopic and gastroscopic treatment of patients with cirrhosis and portal hypertension presenting with bleeding esophageal varices 腹腔镜与胃镜联合治疗肝硬化门脉高压伴食管静脉曲张出血的疗效观察
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.004
Yi-ming Wu, Liyun Zhou, Lifang Zhang, Lu Xu, Minfang Chen, Jun Fang
Objective To evaluate the efficacy of laparoscopic splenectomy plus pericardial devascularization combined with gastroscopic (double endoscopy) treatment of patients with cirrhosis and portal hypertension presenting with bleeding esophagogastric varices. Methods To retrospectively analyze 108 patients who presented with bleeding esophageal and gastric varices at the First Hospital of Jiaxing from March 2013 to March 2018. Of 108 patients, there were 61 males and 47 females, with an average age of 61 years. According to the disease and desires of patients and family members, 28 patients underwent laparoscopic splenectomy plus devascularization (the laparoscopic group), 43 endoscopic treatment (the endoscopic group) and 37 double endoscopic treatment (the double endoscopic group). The liver function, renal function, hemoagglutination and degrees of recurrence of the three groups were compared after operation. Results The renal function, coagulation function, HbA1c in the double endoscopic group was significantly better than that in the other two groups (P<0.05). In the laparoscopic group, there were 4 patients who presented with rebleeding within 36 months, compared with 3 in the endoscopic group, and no patients in the combined group. At 36 months after operation, gastroscopy performed in the laparoscopic group showed mild varices in 8(28.6%) patients, moderate in 9(32.1%), and severe in 11(39.3%). In the endoscopic group, there were 7(16.3%) patients with mild, 26(60.5%) with moderate, and 10(23.2%) with severe. In the double endoscopic group, there were 32(86.5%) patients with mild and 5(13.5%) with moderate. The degrees of recurrence and postoperative esophageal and gastric varices rebleeding in the double endoscopic group were significantly better than those in the laparoscopic group and the endoscopic group (P<0.05). Conclusion Laparoscopic combined with endoscopic treatment was more effective in patients with cirrhosis and portal hypertension who presented with bleeding esophageal varices. Key words: Laparoscopy; Esophageal and gastric varices; Pericardial devascularization; Splenectomy; Gastroscopy
目的评价腹腔镜脾切除加心包断流术联合胃镜(双内镜)治疗肝硬化门静脉高压症合并食管胃底静脉曲张出血的疗效。方法回顾性分析2013年3月至2018年3月在嘉兴市第一医院就诊的108例食管胃底静脉曲张破裂出血患者。108例患者中,男性61例,女性47例,平均年龄61岁。根据患者及家属的疾病和愿望,28例患者接受了腹腔镜脾切除加断流术(腹腔镜组)、43例内镜治疗(内镜组)和37例双内镜治疗(双内镜组)。比较三组患者术后肝功能、肾功能、血凝及复发程度。结果双内镜组肾功能、凝血功能、HbA1c明显优于其他两组(P<0.05),腹腔镜组36个月内再次出血4例,内镜组3例,联合组无1例。术后36个月,腹腔镜组胃镜检查显示轻度静脉曲张8例(28.6%),中度9例(32.1%),重度11例(39.3%)。内镜组轻度7例(16.3%),中度26例(60.5%),重度10例(23.2%)。在双内镜组中,有32名(86.5%)患者为轻度,5名(13.5%)为中度。结论腹腔镜联合内镜治疗肝硬化门静脉高压症合并食管静脉曲张出血疗效显著(P<0.05)。关键词:腹腔镜;食道和胃静脉曲张;心包断流术;脾切除术;胃镜检查
{"title":"Combined laparoscopic and gastroscopic treatment of patients with cirrhosis and portal hypertension presenting with bleeding esophageal varices","authors":"Yi-ming Wu, Liyun Zhou, Lifang Zhang, Lu Xu, Minfang Chen, Jun Fang","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.004","url":null,"abstract":"Objective \u0000To evaluate the efficacy of laparoscopic splenectomy plus pericardial devascularization combined with gastroscopic (double endoscopy) treatment of patients with cirrhosis and portal hypertension presenting with bleeding esophagogastric varices. \u0000 \u0000 \u0000Methods \u0000To retrospectively analyze 108 patients who presented with bleeding esophageal and gastric varices at the First Hospital of Jiaxing from March 2013 to March 2018. Of 108 patients, there were 61 males and 47 females, with an average age of 61 years. According to the disease and desires of patients and family members, 28 patients underwent laparoscopic splenectomy plus devascularization (the laparoscopic group), 43 endoscopic treatment (the endoscopic group) and 37 double endoscopic treatment (the double endoscopic group). The liver function, renal function, hemoagglutination and degrees of recurrence of the three groups were compared after operation. \u0000 \u0000 \u0000Results \u0000The renal function, coagulation function, HbA1c in the double endoscopic group was significantly better than that in the other two groups (P<0.05). In the laparoscopic group, there were 4 patients who presented with rebleeding within 36 months, compared with 3 in the endoscopic group, and no patients in the combined group. At 36 months after operation, gastroscopy performed in the laparoscopic group showed mild varices in 8(28.6%) patients, moderate in 9(32.1%), and severe in 11(39.3%). In the endoscopic group, there were 7(16.3%) patients with mild, 26(60.5%) with moderate, and 10(23.2%) with severe. In the double endoscopic group, there were 32(86.5%) patients with mild and 5(13.5%) with moderate. The degrees of recurrence and postoperative esophageal and gastric varices rebleeding in the double endoscopic group were significantly better than those in the laparoscopic group and the endoscopic group (P<0.05). \u0000 \u0000 \u0000Conclusion \u0000Laparoscopic combined with endoscopic treatment was more effective in patients with cirrhosis and portal hypertension who presented with bleeding esophageal varices. \u0000 \u0000 \u0000Key words: \u0000Laparoscopy; Esophageal and gastric varices; Pericardial devascularization; Splenectomy; Gastroscopy","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"173-176"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47253077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of laparoscopy in liver metastasis of colorectal cancer 腹腔镜在结直肠癌肝转移中的应用
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.019
Xingchen Li, Zhi-yu Li, X. Bi
Surgical resection is the best therapeutic option for patients with colorectal cancer liver metastasis. As patients with synchronous liver metastases from colorectal cancer, simultaneous resection of primary and metastatic lesions has been widely used. With the gradual maturation of laparoscopic technology, its minimally invasive, safe and effective characteristics make it better for simultaneous resection of colorectal cancer with liver metastasis. On the basis of grasping the principles of surgical treatment for colorectal cancer with liver metastasis, reasonable and full combination of the advantages of laparoscopy can enable patients get greater benefits with minimal trauma. Key words: Laparoscopy; Colorectal cancer; Liver metastasis; Simultaneous resection
手术切除是结直肠癌癌症肝转移患者的最佳治疗选择。作为癌症同步肝转移的患者,原发灶和转移灶同时切除已被广泛应用。随着腹腔镜技术的逐渐成熟,其微创、安全、有效的特点使其更适合同时切除伴有肝转移的结直肠癌癌症。在掌握癌症肝转移手术治疗原则的基础上,合理、充分结合腹腔镜的优点,使患者在创伤最小的情况下获得更大的治疗效果。关键词:腹腔镜;癌症大肠癌;肝转移;同时切除
{"title":"Application of laparoscopy in liver metastasis of colorectal cancer","authors":"Xingchen Li, Zhi-yu Li, X. Bi","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.019","url":null,"abstract":"Surgical resection is the best therapeutic option for patients with colorectal cancer liver metastasis. As patients with synchronous liver metastases from colorectal cancer, simultaneous resection of primary and metastatic lesions has been widely used. With the gradual maturation of laparoscopic technology, its minimally invasive, safe and effective characteristics make it better for simultaneous resection of colorectal cancer with liver metastasis. On the basis of grasping the principles of surgical treatment for colorectal cancer with liver metastasis, reasonable and full combination of the advantages of laparoscopy can enable patients get greater benefits with minimal trauma. \u0000 \u0000Key words: \u0000Laparoscopy; Colorectal cancer; Liver metastasis; Simultaneous resection","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"226-229"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42956678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic efficacy of external and internal-external percutaneous transhepatic biliary drainage in patients with malignant obstructive jaundice 体外及内外经皮经肝胆道引流治疗恶性梗阻性黄疸的疗效观察
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.011
Yi-lei Deng, Menghao Zhou, Longshuan Zhao
Objective To investigate the efficacy of two different percutaneous transhepatic biliary drainage (PTBD) procedures for malignant obstructive jaundice. Methods The clinical data of 132 patients with malignant obstructive jaundice who underwent PTBD were retrospectively analyzed. According to whether the tip of the catheter was placed in the intestine, 132 patients were divided into the external drainage group and the internal-external drainage group. The effect on decrease in jaundice (total bilirubin, direct bilirubin levels), postoperative complications, and hospitalization costs of the two drainage methods were compared. Results Of the 132 patients who were included in this study, there were 91 males and 41 females, aged 18 to 85 years. The external drainage group included 81 patients, and the internal and external drainage group included 51 patients. The total bilirubin [(190.2±41.8)μmol/L vs. (294.9±38.3) μmol/L] and direct bilirubin [(155.4±30.9)μmol/L vs. (242.1±39.6) μmol/L] levels in the external drainage group and the total bilirubin [(179.3±37.1)μmol/L vs. (288.1±35.4)μmol/L] and direct bilirubin [(147.7±32.5)μmol/L vs. (233.7±36.1)μmol/L] levels in the internal-external drainage group were significantly decreased after surgery (all P<0.05). The incidences of reoperation, re-intubation or bilateral catheterization [15.6%(8/51) vs. 3.7%(3/81)] and biliary tract infection [50.9%(26/51) vs. 27.1%(22/81)] in the internal-external drainage group was significantly higher than that in the external drainage group (all P<0.05). The mortality rate due to biliary tract infection in the internal-external drainage group was significantly higher than that of the external drainage group [7.8%(4/51) vs. 0, P<0.05]. Intestinal-derived bacteria such as Escherichia coli, Enterococcus faecium, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the main bacteria in the biliary tract infections of the two groups. The hospitalization cost of patients in the internal-external drainage group was significantly higher than that in the external drainage group [(34 928.0±3 693.0) yuan vs. (29 360.0±3 219.0) yuan, P<0.05]. Conclusion Both PTBD external drainage and internal and external drainage could alleviate the symptoms of jaundice quickly and effectively. Key words: Jaundice, obstructive; Percutaneous transhepatic biliary drainage; Biliary tract infection
目的探讨两种不同的经皮经肝胆道引流术治疗恶性梗阻性黄疸的疗效。方法回顾性分析132例恶性梗阻性黄疸行PTBD的临床资料。根据导管尖端是否放置在肠内,将132例患者分为外引流组和内外引流组。比较两种引流方式对降低黄疸(总胆红素、直接胆红素水平)、术后并发症及住院费用的影响。结果本研究纳入的132例患者中,男性91例,女性41例,年龄18 ~ 85岁。外引流组81例,内外引流组51例。体外引流组总胆红素[(190.2±41.8)μmol/L比(294.9±38.3)μmol/L]、直接胆红素[(155.4±30.9)μmol/L比(242.1±39.6)μmol/L]水平及内外引流组总胆红素[(179.3±37.1)μmol/L比(288.1±35.4)μmol/L]、直接胆红素[(147.7±32.5)μmol/L比(233.7±36.1)μmol/L]水平术后均显著降低(P<0.05)。内外引流组再手术、再插管或双侧置管发生率[15.6%(8/51)比3.7%(3/81)]和胆道感染发生率[50.9%(26/51)比27.1%(22/81)]显著高于外引流组(P<0.05)。外置引流组胆道感染死亡率显著高于外置引流组[7.8%(4/51)vs. 0, P<0.05]。两组胆道感染以大肠杆菌、屎肠球菌、铜绿假单胞菌、肺炎克雷伯菌等肠道源性细菌为主。内外引流组患者住院费用显著高于外引流组[(34 928.0±3 693.0)元vs(29 360.0±3 219.0)元,P<0.05]。结论PTBD外置引流和内外置引流均能快速有效地缓解黄疸症状。关键词:黄疸;梗阻性;经皮经肝胆道引流;胆道感染
{"title":"Therapeutic efficacy of external and internal-external percutaneous transhepatic biliary drainage in patients with malignant obstructive jaundice","authors":"Yi-lei Deng, Menghao Zhou, Longshuan Zhao","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.011","url":null,"abstract":"Objective \u0000To investigate the efficacy of two different percutaneous transhepatic biliary drainage (PTBD) procedures for malignant obstructive jaundice. \u0000 \u0000 \u0000Methods \u0000The clinical data of 132 patients with malignant obstructive jaundice who underwent PTBD were retrospectively analyzed. According to whether the tip of the catheter was placed in the intestine, 132 patients were divided into the external drainage group and the internal-external drainage group. The effect on decrease in jaundice (total bilirubin, direct bilirubin levels), postoperative complications, and hospitalization costs of the two drainage methods were compared. \u0000 \u0000 \u0000Results \u0000Of the 132 patients who were included in this study, there were 91 males and 41 females, aged 18 to 85 years. The external drainage group included 81 patients, and the internal and external drainage group included 51 patients. The total bilirubin [(190.2±41.8)μmol/L vs. (294.9±38.3) μmol/L] and direct bilirubin [(155.4±30.9)μmol/L vs. (242.1±39.6) μmol/L] levels in the external drainage group and the total bilirubin [(179.3±37.1)μmol/L vs. (288.1±35.4)μmol/L] and direct bilirubin [(147.7±32.5)μmol/L vs. (233.7±36.1)μmol/L] levels in the internal-external drainage group were significantly decreased after surgery (all P<0.05). The incidences of reoperation, re-intubation or bilateral catheterization [15.6%(8/51) vs. 3.7%(3/81)] and biliary tract infection [50.9%(26/51) vs. 27.1%(22/81)] in the internal-external drainage group was significantly higher than that in the external drainage group (all P<0.05). The mortality rate due to biliary tract infection in the internal-external drainage group was significantly higher than that of the external drainage group [7.8%(4/51) vs. 0, P<0.05]. Intestinal-derived bacteria such as Escherichia coli, Enterococcus faecium, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the main bacteria in the biliary tract infections of the two groups. The hospitalization cost of patients in the internal-external drainage group was significantly higher than that in the external drainage group [(34 928.0±3 693.0) yuan vs. (29 360.0±3 219.0) yuan, P<0.05]. \u0000 \u0000 \u0000Conclusion \u0000Both PTBD external drainage and internal and external drainage could alleviate the symptoms of jaundice quickly and effectively. \u0000 \u0000 \u0000Key words: \u0000Jaundice, obstructive; Percutaneous transhepatic biliary drainage; Biliary tract infection","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"203-207"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41460014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rupture of hepatic artery pseudoaneurysm after liver transplantation: a report of three patients 肝移植术后肝动脉假性动脉瘤破裂3例报告
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.006
Xie Zhantao, Zhao Huibo, W. Weiwei, Yuan Zhenhua, Cheng Yongfeng, Sun Jianjun, Wei Sidong, Cheng Guoyong
Objective To report on 3 patients who presented with rupture of hepatic artery pseudoaneurysm after liver transplantation. Methods From April 2010 to April 2019, 3 patients with hepatic artery pseudoaneurysm rupture after liver transplantation treated at the Department of Hepatobiliary and Pancreatic Surgery, Henan Provincial People's Hospital were studied. The possible causes, clinical manifestations, diagnosis and treatment were retrospectively analyzed. Results Rupture of hepatic artery pseudoaneurysm occurred on the19th, 28th and 63th days after transplantation. The 3 patients all presented with hematochezia and abdominal pain, while 2 patients presented with hematemesis. Two patients had bile leakage and abdominal infection. All the 3 patients presented with fever. Patient 1 who was diagnosed by laparotomy died of liver failure. Patient 2 underwent interventional embolization of hepatic artery and died of liver failure also. Patient 3 underwent surgical resection of the pseudoaneurysm followed by hepatic artery reconstruction, but died of repeat abdominal hemorrhage. Conclusion Hepatic artery pseudoaneurysm after liver transplantation has a long latent period and is difficult to diagnose at an early stage. Early detection of this life-threatening complication is the key to improve survival. Early treatment of biliary leakage, abdominal infection and other complications help to prevent development of pseudoaneurysms. Key words: Liver transplantation; Pseudoaneurysm; Abdominal infection
目的报告3例肝移植术后出现肝动脉假性动脉瘤破裂的病例。方法对2010年4月至2019年4月河南省人民医院肝胆胰外科收治的3例肝移植术后肝动脉假性动脉瘤破裂患者的临床资料进行分析。回顾性分析可能的病因、临床表现、诊断及治疗方法。结果肝动脉假性动脉瘤于移植后第19、28、63天破裂。3例患者均出现便血、腹痛,2例患者出现呕血。2例患者出现胆漏及腹部感染。3例患者均有发热表现。经剖腹手术诊断的患者1死于肝功能衰竭。患者2行肝动脉介入栓塞术,同样死于肝功能衰竭。患者3行假性动脉瘤手术切除及肝动脉重建,但因反复腹部出血死亡。结论肝移植术后肝动脉假性动脉瘤潜伏期长,早期诊断困难。早期发现这种危及生命的并发症是提高生存率的关键。早期治疗胆漏、腹腔感染和其他并发症有助于预防假性动脉瘤的发展。关键词:肝移植;假动脉瘤;腹部感染
{"title":"Rupture of hepatic artery pseudoaneurysm after liver transplantation: a report of three patients","authors":"Xie Zhantao, Zhao Huibo, W. Weiwei, Yuan Zhenhua, Cheng Yongfeng, Sun Jianjun, Wei Sidong, Cheng Guoyong","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.006","url":null,"abstract":"Objective \u0000To report on 3 patients who presented with rupture of hepatic artery pseudoaneurysm after liver transplantation. \u0000 \u0000 \u0000Methods \u0000From April 2010 to April 2019, 3 patients with hepatic artery pseudoaneurysm rupture after liver transplantation treated at the Department of Hepatobiliary and Pancreatic Surgery, Henan Provincial People's Hospital were studied. The possible causes, clinical manifestations, diagnosis and treatment were retrospectively analyzed. \u0000 \u0000 \u0000Results \u0000Rupture of hepatic artery pseudoaneurysm occurred on the19th, 28th and 63th days after transplantation. The 3 patients all presented with hematochezia and abdominal pain, while 2 patients presented with hematemesis. Two patients had bile leakage and abdominal infection. All the 3 patients presented with fever. Patient 1 who was diagnosed by laparotomy died of liver failure. Patient 2 underwent interventional embolization of hepatic artery and died of liver failure also. Patient 3 underwent surgical resection of the pseudoaneurysm followed by hepatic artery reconstruction, but died of repeat abdominal hemorrhage. \u0000 \u0000 \u0000Conclusion \u0000Hepatic artery pseudoaneurysm after liver transplantation has a long latent period and is difficult to diagnose at an early stage. Early detection of this life-threatening complication is the key to improve survival. Early treatment of biliary leakage, abdominal infection and other complications help to prevent development of pseudoaneurysms. \u0000 \u0000 \u0000Key words: \u0000Liver transplantation; Pseudoaneurysm; Abdominal infection","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"180-182"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45124998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary mature teratoma of the liver with malignant transformation: a case report and literature review 原发性肝成熟畸胎瘤伴恶性转化1例报告并文献复习
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.017
Xiong-fei Chen, Guanglei Tian, Y. Meng, Jinguo Wang, Kalifu Baheti
患者男性,59岁,汉族,河北人。因肝占位就诊于当地医院,考虑肝包虫病,来新疆维吾尔自治区人民医院诊治。无包虫疫区生活史,包虫抗体检查均阴性。腹部CT诊断:肝内巨大混杂密度占位:畸胎瘤?包虫?患者行右半肝切除术。术后大体标本可见成熟毛发、脂肪、软骨和骨骼等,病理诊断肝成熟型畸胎瘤伴恶变,成分为鳞状细胞癌及腺癌。
The patient is a male, 59 years old, Han Chinese, from Hebei. Due to liver occupying lesions, I sought medical attention from a local hospital and considered liver echinococcosis. I came to the People's Hospital of Xinjiang Uygur Autonomous Region for diagnosis and treatment. There is no history of life in a hydatid infected area, and all hydatid antibody tests are negative. Abdominal CT diagnosis: huge mixed density mass in the liver: teratoma? Hydatid? The patient underwent a right hemihepatectomy. After surgery, mature hair, fat, cartilage, and bones can be seen in the gross specimen. Pathological diagnosis shows that liver mature teratoma with malignant transformation is composed of squamous cell carcinoma and adenocarcinoma.
{"title":"Primary mature teratoma of the liver with malignant transformation: a case report and literature review","authors":"Xiong-fei Chen, Guanglei Tian, Y. Meng, Jinguo Wang, Kalifu Baheti","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.017","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.017","url":null,"abstract":"患者男性,59岁,汉族,河北人。因肝占位就诊于当地医院,考虑肝包虫病,来新疆维吾尔自治区人民医院诊治。无包虫疫区生活史,包虫抗体检查均阴性。腹部CT诊断:肝内巨大混杂密度占位:畸胎瘤?包虫?患者行右半肝切除术。术后大体标本可见成熟毛发、脂肪、软骨和骨骼等,病理诊断肝成熟型畸胎瘤伴恶变,成分为鳞状细胞癌及腺癌。","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"222-223"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45257432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect and mechanism of silent information regulator 6 on gluconeogenesis in chronic-on-acute liver failure 沉默信息调节因子6对慢性-急性肝功能衰竭糖异生的影响及其机制
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.002
W. Kang, Jing Wu, Ju-shan Wu, Shichun Lu, Q. Meng
Objective To investigate the effect and mechanism of silent information regulator 6 (SIRT6) and gluconeogenesis-dependent rate-limiting enzymes in hepatocytes in oxidative stress injury rats and chronic-on-acute (sub-acute) liver failure (ACLF) patients. Methods From August 2016 to May 2018, 10 patients with ACLF from Beijing Youan Hospital Affiliated to Capital Medical University were included in the ACLF group, and 10 normal donors were included in the normal control group. Level of fasting blood glucose, total bilirubin, albumin, and alanine aminotransferase (ALT) were studied. Sprague Dawley rat hepatocytes were isolated and divided into control group (without any intervention), model group (H2O2 intervention for 6 h), mammalian rapamycin target protein (mTOR) activation group (mTOR activation was added to the model group), mTOR inhibition group (mTOR inhibitor was added on the basis of the model group). Protein electrophoresis and polymerase chain reaction was used to detect the relative expression of glucose-6-phosphatase (G6P), phosphoenolpyruvate (PEPCK), SIRT6, and mTOR. Results The ALT and total bilirubin level in ACLF group were significantly higher than those in the normal control group, and the differences were statistically significant (all P<0.05). In ACLF group, level of SIRT6 (0.15±0.07) μg/L and fasting blood glucose (3.19±0.59) mmol/L were significantly lower than those in the normal control group (0.46±0.15) μg/L and (7.07±2.07) mmol/L, the difference was statistically significant (all P<0.05). The relative expression of PEPCK and G6P protein in liver tissue of ACLF group was significantly lower than that of normal control group. The relative expression of SIRT6, PEPCK, and G6P in the model group were lower than those in the control group, and the differences were statistically significant (all P<0.05). When mTOR is activated, the relative expression of PEPCK, G6P, and SIRT6 was higher than those in the model group, and after mTOR inhibition, the relative expression of PEPCK, G6P, and SIRT6 was lower than in the model group. Conclusion ACLF, SIRT6 may inhibit gluconeogenesis, and increased the occurrence of hypoglycemia through activating mTOR signaling pathway. Blocking of SIRT6 levels may slow down the progress of ACLF. Key words: Acute-on-chronic liver failure; Glucose-6-phosphatase; Phosphoenolpyruvate carboxykinase; Silent information regulator 6; Mammalian rapamycin target protein
目的探讨沉默信息调节因子6 (SIRT6)和糖异生依赖性限速酶在氧化应激损伤大鼠和慢性急性(亚急性)肝衰竭(ACLF)患者肝细胞中的作用及其机制。方法选取2016年8月~ 2018年5月首都医科大学附属北京友安医院ACLF患者10例作为ACLF组,正常供者10例作为正常对照组。观察空腹血糖、总胆红素、白蛋白、谷丙转氨酶(ALT)水平。分离Sprague Dawley大鼠肝细胞,分为对照组(不加干预)、模型组(H2O2干预6 h)、哺乳动物雷帕霉素靶蛋白(mTOR)激活组(模型组加mTOR激活)、mTOR抑制组(在模型组基础上加mTOR抑制剂)。采用蛋白电泳和聚合酶链反应检测葡萄糖-6-磷酸酶(G6P)、磷酸烯醇丙酮酸(PEPCK)、SIRT6和mTOR的相对表达。结果ACLF组ALT、总胆红素水平显著高于正常对照组,差异均有统计学意义(P<0.05)。ACLF组患者SIRT6水平(0.15±0.07)μg/L、空腹血糖水平(3.19±0.59)mmol/L显著低于正常对照组(0.46±0.15)μg/L和(7.07±2.07)mmol/L,差异均有统计学意义(P<0.05)。ACLF组肝组织中PEPCK和G6P蛋白的相对表达量显著低于正常对照组。模型组SIRT6、PEPCK、G6P的相对表达量均低于对照组,差异均有统计学意义(P<0.05)。mTOR激活后,PEPCK、G6P、SIRT6的相对表达量高于模型组,mTOR抑制后,PEPCK、G6P、SIRT6的相对表达量低于模型组。结论ACLF、SIRT6可能通过激活mTOR信号通路抑制糖异生,增加低血糖的发生。阻断SIRT6水平可减缓ACLF的进展。关键词:急性-慢性肝衰竭;Glucose-6-phosphatase;磷酸烯醇丙酮酸carboxykinase;静音信息调节器6;哺乳动物雷帕霉素靶蛋白
{"title":"Effect and mechanism of silent information regulator 6 on gluconeogenesis in chronic-on-acute liver failure","authors":"W. Kang, Jing Wu, Ju-shan Wu, Shichun Lu, Q. Meng","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.002","url":null,"abstract":"Objective \u0000To investigate the effect and mechanism of silent information regulator 6 (SIRT6) and gluconeogenesis-dependent rate-limiting enzymes in hepatocytes in oxidative stress injury rats and chronic-on-acute (sub-acute) liver failure (ACLF) patients. \u0000 \u0000 \u0000Methods \u0000From August 2016 to May 2018, 10 patients with ACLF from Beijing Youan Hospital Affiliated to Capital Medical University were included in the ACLF group, and 10 normal donors were included in the normal control group. Level of fasting blood glucose, total bilirubin, albumin, and alanine aminotransferase (ALT) were studied. Sprague Dawley rat hepatocytes were isolated and divided into control group (without any intervention), model group (H2O2 intervention for 6 h), mammalian rapamycin target protein (mTOR) activation group (mTOR activation was added to the model group), mTOR inhibition group (mTOR inhibitor was added on the basis of the model group). Protein electrophoresis and polymerase chain reaction was used to detect the relative expression of glucose-6-phosphatase (G6P), phosphoenolpyruvate (PEPCK), SIRT6, and mTOR. \u0000 \u0000 \u0000Results \u0000The ALT and total bilirubin level in ACLF group were significantly higher than those in the normal control group, and the differences were statistically significant (all P<0.05). In ACLF group, level of SIRT6 (0.15±0.07) μg/L and fasting blood glucose (3.19±0.59) mmol/L were significantly lower than those in the normal control group (0.46±0.15) μg/L and (7.07±2.07) mmol/L, the difference was statistically significant (all P<0.05). The relative expression of PEPCK and G6P protein in liver tissue of ACLF group was significantly lower than that of normal control group. The relative expression of SIRT6, PEPCK, and G6P in the model group were lower than those in the control group, and the differences were statistically significant (all P<0.05). When mTOR is activated, the relative expression of PEPCK, G6P, and SIRT6 was higher than those in the model group, and after mTOR inhibition, the relative expression of PEPCK, G6P, and SIRT6 was lower than in the model group. \u0000 \u0000 \u0000Conclusion \u0000ACLF, SIRT6 may inhibit gluconeogenesis, and increased the occurrence of hypoglycemia through activating mTOR signaling pathway. Blocking of SIRT6 levels may slow down the progress of ACLF. \u0000 \u0000 \u0000Key words: \u0000Acute-on-chronic liver failure; Glucose-6-phosphatase; Phosphoenolpyruvate carboxykinase; Silent information regulator 6; Mammalian rapamycin target protein","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"165-169"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45813811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic anatomical hepatectomy of segment VII for hepatocellular carcinoma by the dorsal right hepatic vein first approach: a case report 腹腔镜右肝背静脉第一入路第七节肝切除术治疗肝癌1例
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.018
Hui Zhang, Xiaohui Duan, X. Mao, Xiaoti Liu, Y. Shen
患者男性,57岁,腹部增强CT提示肝Ⅱ段、Ⅶ段占位,行腹腔镜肝Ⅶ段切除及左肝外叶切除。切除左肝外叶后,从背侧入路沿肝右静脉根部离断肝实质及肝右静脉回流支。随后转为前入路,沿缺血分界线自肝边缘向第二肝门逐步离断肝实质,直至背侧入路肝离断面。完成Ⅶ段解剖性切除。Ⅶ段切除手术时间约150 min,肝门阻断4次,共60 min,出血量100 ml,未输血。随访8个月无肝癌复发或转移。
The patient is a 57-year-old male who underwent laparoscopic liver segment VII resection and left lateral lobe resection, with abdominal enhanced CT showing liver segment II and VII masses. After resection of the left outer lobe of the liver, the liver parenchyma and right hepatic venous reflux branch were severed along the root of the right hepatic vein through a dorsal approach. Subsequently, the anterior approach was used, and the liver parenchyma was gradually severed from the edge of the liver towards the second hepatic portal along the ischemic boundary, until the dorsal approach liver detachment section. Complete anatomical resection of segment VII. The duration of the seventh segment resection surgery was approximately 150 minutes, with 4 hepatic portal blockages for a total of 60 minutes. The bleeding volume was 100 ml, and no blood transfusion was performed. There was no recurrence or metastasis of liver cancer during an 8-month follow-up.
{"title":"Laparoscopic anatomical hepatectomy of segment VII for hepatocellular carcinoma by the dorsal right hepatic vein first approach: a case report","authors":"Hui Zhang, Xiaohui Duan, X. Mao, Xiaoti Liu, Y. Shen","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.018","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.018","url":null,"abstract":"患者男性,57岁,腹部增强CT提示肝Ⅱ段、Ⅶ段占位,行腹腔镜肝Ⅶ段切除及左肝外叶切除。切除左肝外叶后,从背侧入路沿肝右静脉根部离断肝实质及肝右静脉回流支。随后转为前入路,沿缺血分界线自肝边缘向第二肝门逐步离断肝实质,直至背侧入路肝离断面。完成Ⅶ段解剖性切除。Ⅶ段切除手术时间约150 min,肝门阻断4次,共60 min,出血量100 ml,未输血。随访8个月无肝癌复发或转移。","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"224-225"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44056394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study on preoperative portal vein embolization using tris-acryl gelatin microspheres versus coils 术前应用三丙烯酸酯明胶微球与线圈栓塞门静脉的比较研究
Q4 Medicine Pub Date : 2020-03-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2020.03.012
Lei Yuan, Yingjun Wu, Yun X. Xu, Kaijian Chu, F. Feng, Xiaobing Wu, B. Yi, Yefa Yang, Xiaoqing Jiang
Objective To compare preoperative portal vein embolization (PVE) using tris-acryl gelatin microspheres (TAGM) versus coils. Methods From March 2016 to June 2018, 21 consecutive patients with a future liver remnant (FLR) ratio of less than 45% before planned major hepatectomy for malignant or benign liver diseases were enrolled from the First Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital into this study. The patients were divided to receive portal vein embolization (PVE) using TAGM distally and coils proximally (the TC group) and PVE using multiple coils (the CC group). Post-PVE complications, liver function, routine blood tests; FLR hyperplasia, types of liver resection, operation time, intraoperative blood loss, and postoperative complications were compared between the two groups. Results Eight patients were included in the TC group. There were 4 males and 4 females, with a mean age of (55.3±7.7) years. Of 13 patients included into the CC group, there were 11 males and 2 females, with a mean age of (52.6±11.3) years. There were no significant differences in sex, age, types of hepatic diseases, volume of FLR, ratio of FLR, ratio of standard FLR, types of surgery, operation duration, blood loss, major complications, and liver failure rates between the two groups. All patients in the two groups had successful PVE. The TC group developed effective growth of volume of FLR with one patient who failed to undergo surgery because of tumor progression. In the CC group, four patients failed to undergo liver resection: one patient developed thrombosis of the left branch and main trunk of portal vein; tumor progression occurred in one patient and two patients had insufficient FLR growth. Compared with the CC group, the TC group had a significantly higher volume of FLR hyperplasia [(9.0±2.8) % vs. (5.2±3.8) %, P 0.05], a greater but insignificant increase in percentage of proliferation [(33.6±20.1) % vs. (20.9±15.1) %, P>0.05]. Conclusions This study showed that PVE with TAGM plus coils is safe and effective. It induced a better degree of hypertrophy of FLR compared to PVE using multiple coils. Key words: Liver diseases; Portal vein embolization; Tris-acryl gelatin microsphere; Coils; Major hepatectomy
目的比较术前使用三丙烯明胶微球(TAGM)与线圈栓塞门静脉(PVE)的效果。方法2016年3月至2018年6月,东方肝胆外科医院胆道外科一科连续21例因恶性或良性肝病计划大肝切除术前未来肝残(FLR)率小于45%的患者纳入研究。患者分为两组,分别采用远端TAGM +近端线圈门静脉栓塞术(TC组)和多线圈门静脉栓塞术(CC组)。pve术后并发症、肝功能、血常规检查;比较两组患者FLR增生情况、肝切除类型、手术时间、术中出血量及术后并发症。结果8例患者纳入TC组。男4例,女4例,平均年龄(55.3±7.7)岁。CC组13例患者,男性11例,女性2例,平均年龄(52.6±11.3)岁。两组患者在性别、年龄、肝病类型、FLR体积、FLR比率、标准FLR比率、手术类型、手术时间、出血量、主要并发症、肝功能衰竭发生率等方面均无显著差异。两组患者均成功进行PVE治疗。TC组FLR体积有效增长,1例患者因肿瘤进展而未能接受手术。CC组4例肝切除失败:1例门静脉左支主干血栓形成;1例患者发生肿瘤进展,2例患者FLR生长不足。与CC组相比,TC组FLR增生体积显著增加[(9.0±2.8)%比(5.2±3.8)%,P 0.05],增殖百分比显著增加[(33.6±20.1)%比(20.9±15.1)%,P 0.05]。结论TAGM +线圈的PVE是安全有效的。与使用多个线圈的PVE相比,它诱导的FLR肥大程度更好。关键词:肝脏疾病;门静脉栓塞;三丙烯明胶微球;线圈;主要肝切除术
{"title":"A comparative study on preoperative portal vein embolization using tris-acryl gelatin microspheres versus coils","authors":"Lei Yuan, Yingjun Wu, Yun X. Xu, Kaijian Chu, F. Feng, Xiaobing Wu, B. Yi, Yefa Yang, Xiaoqing Jiang","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.03.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.03.012","url":null,"abstract":"Objective \u0000To compare preoperative portal vein embolization (PVE) using tris-acryl gelatin microspheres (TAGM) versus coils. \u0000 \u0000 \u0000Methods \u0000From March 2016 to June 2018, 21 consecutive patients with a future liver remnant (FLR) ratio of less than 45% before planned major hepatectomy for malignant or benign liver diseases were enrolled from the First Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital into this study. The patients were divided to receive portal vein embolization (PVE) using TAGM distally and coils proximally (the TC group) and PVE using multiple coils (the CC group). Post-PVE complications, liver function, routine blood tests; FLR hyperplasia, types of liver resection, operation time, intraoperative blood loss, and postoperative complications were compared between the two groups. \u0000 \u0000 \u0000Results \u0000Eight patients were included in the TC group. There were 4 males and 4 females, with a mean age of (55.3±7.7) years. Of 13 patients included into the CC group, there were 11 males and 2 females, with a mean age of (52.6±11.3) years. There were no significant differences in sex, age, types of hepatic diseases, volume of FLR, ratio of FLR, ratio of standard FLR, types of surgery, operation duration, blood loss, major complications, and liver failure rates between the two groups. All patients in the two groups had successful PVE. The TC group developed effective growth of volume of FLR with one patient who failed to undergo surgery because of tumor progression. In the CC group, four patients failed to undergo liver resection: one patient developed thrombosis of the left branch and main trunk of portal vein; tumor progression occurred in one patient and two patients had insufficient FLR growth. Compared with the CC group, the TC group had a significantly higher volume of FLR hyperplasia [(9.0±2.8) % vs. (5.2±3.8) %, P 0.05], a greater but insignificant increase in percentage of proliferation [(33.6±20.1) % vs. (20.9±15.1) %, P>0.05]. \u0000 \u0000 \u0000Conclusions \u0000This study showed that PVE with TAGM plus coils is safe and effective. It induced a better degree of hypertrophy of FLR compared to PVE using multiple coils. \u0000 \u0000 \u0000Key words: \u0000Liver diseases; Portal vein embolization; Tris-acryl gelatin microsphere; Coils; Major hepatectomy","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"26 1","pages":"208-212"},"PeriodicalIF":0.0,"publicationDate":"2020-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47319152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华肝胆外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1